Covered recipient · General Payments record
ANGELA B TREML
Allopathic & Osteopathic Physicians Pathology Blood Banking & Transfusion Medicine
General Payments · PY2022–2024
$5,590.57
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $1,525.12 | 5 |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,425.00 | 1 |
| Food and Beverage | $719.87 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BioLineRx USA, Inc. | $2,238.91 | 5 |
| CSL Behring | $1,281.08 | 11 |
| Cerus Corporation | $150.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| BioLineRx USA, Inc. | $85.00 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145039875 | CMS |
| BioLineRx USA, Inc. | $33.45 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145039873 | CMS |
| BioLineRx USA, Inc. | $1,425.00 | 11/12/2024 | Compensation for serving as faculty or as a speaker for a medical education program | Undisputed | 01/23/2026 | 1145039877 | CMS |
| BioLineRx USA, Inc. | $468.43 | 11/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1145039879 | CMS |
| BioLineRx USA, Inc. | $227.03 | 11/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1145039881 | CMS |
| Cerus Corporation | $150.00 | 10/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137005244 | CMS |
| CSL Behring | $32.86 | 04/27/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1134608717 | CMS |
| CSL Behring | $67.67 | 04/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134608719 | CMS |
| CSL Behring | $687.71 | 04/28/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1134608721 | CMS |
| CSL Behring | $46.31 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134608723 | CMS |
| CSL Behring | $110.11 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134608725 | CMS |
| CSL Behring | $25.28 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134608727 | CMS |
| CSL Behring | $10.78 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134608729 | CMS |
| CSL Behring | $8.46 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134608731 | CMS |
| CSL Behring | $109.09 | 04/29/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1134608733 | CMS |
| CSL Behring | $62.21 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134608735 | CMS |
| CSL Behring | $120.60 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134608737 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.